1. Review of the 1985 yellow card reports received by the CSM

   Newsletter Article 07 February 2013 Pages: 2 - 2

2. Fatal liver failure with paediatric use of valproic acid

   Newsletter Article 07 February 2013 Pages: 2 - 2

3. Treatment of digoxin overdose with digoxin-specific Fab antibodies

   Newsletter Article 07 February 2013 Pages: 2 - 3

4. Overdose with ‘second generation antidepressants’: management and toxicity

   Newsletter Article 07 February 2013 Pages: 3 - 3

5. A case of dextromethorphan dependence

   Newsletter Article 07 February 2013 Pages: 3 - 3

6. An hypothesis suggesting drug toxicity is related to membrane effects

   Newsletter Article 07 February 2013 Pages: 3 - 3

7. An overview of insulin allergy

   Newsletter Article 07 February 2013 Pages: 3 - 4

8. Staphylococcal infection during etretinate therapy

   Newsletter Article 07 February 2013 Pages: 4 - 4

9. Antacids

   Newsletter Article 07 February 2013 Pages: 4 - 4

10. Antacid interaction

    Newsletter Article 07 February 2013 Pages: 4 - 5

11. Anti-inflammatories, non-steroidal

    Newsletter Article 07 February 2013 Pages: 5 - 5

12. Beclomethasone dipropionate

    Newsletter Article 07 February 2013 Pages: 5 - 5

13. Captopril interaction⋆

    Newsletter Article 07 February 2013 Pages: 5 - 5

14. Cefradine⋆

    Newsletter Article 07 February 2013 Pages: 5 - 5

15. Chlorpromazine interaction see Captopril interaction

    Newsletter Article 07 February 2013 Pages: 5 - 5

16. Diclofenac interaction

    Newsletter Article 07 February 2013 Pages: 5 - 5

17. Oral contraceptives and breast cancer

    Newsletter Article 07 February 2013 Pages: 6 - 7

18. Dihydroergotamine mesylate + heparin

    Newsletter Article 07 February 2013 Pages: 7 - 7

19. Epoprostenol⋆

    Newsletter Article 07 February 2013 Pages: 7 - 8

20. Ethinylestradiol⋆

    Newsletter Article 07 February 2013 Pages: 8 - 8

21. Fenoprofen⋆

    Newsletter Article 07 February 2013 Pages: 8 - 8

22. Fluoxetine interaction

    Newsletter Article 07 February 2013 Pages: 8 - 8

23. Heparin adverse reactions see Dihydroergotamine mesylate + heparin

    Newsletter Article 07 February 2013 Pages: 8 - 8

24. Heparin interaction

    Newsletter Article 07 February 2013 Pages: 8 - 9

25. Imipramine

    Newsletter Article 07 February 2013 Pages: 9 - 9

26. Indomethacin

    Newsletter Article 07 February 2013 Pages: 9 - 9

27. Isoniazid

    Newsletter Article 07 February 2013 Pages: 9 - 9

28. Josamycin

    Newsletter Article 07 February 2013 Pages: 9 - 10

29. Meglumine diatrizoate⋆

    Newsletter Article 07 February 2013 Pages: 10 - 10

30. Mitoxantrone⋆

    Newsletter Article 07 February 2013 Pages: 10 - 10

31. Nifedipine

    Newsletter Article 07 February 2013 Pages: 10 - 10

32. Nifedipine overdose

    Newsletter Article 07 February 2013 Pages: 10 - 10

33. Nitroglycerin interaction see Heparin interaction

    Newsletter Article 07 February 2013 Pages: 10 - 10

34. OKT3

    Newsletter Article 07 February 2013 Pages: 10 - 10

35. Piroxicam

    Newsletter Article 07 February 2013 Pages: 11 - 11

36. Ranitidine interaction see Antacid interaction

    Newsletter Article 07 February 2013 Pages: 11 - 11

37. Quinidine⋆

    Newsletter Article 07 February 2013 Pages: 11 - 11

38. Recombinant tissue plasminogen activator

    Newsletter Article 07 February 2013 Pages: 11 - 11

39. Sodium cromoglycate

    Newsletter Article 07 February 2013 Pages: 11 - 11

40. Triamterene interaction see Diclofenac interaction

    Newsletter Article 07 February 2013 Pages: 11 - 11

41. Tryptophan interaction see Fluoxetine interaction

    Newsletter Article 07 February 2013 Pages: 11 - 11

42. Theophylline overdose

    Newsletter Article 07 February 2013 Pages: 11 - 11

43. Ticarcillin

    Newsletter Article 07 February 2013 Pages: 11 - 12

44. Adverse effects of fenbufen

    Newsletter Article 07 February 2013 Pages: 12 - 12